Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript

Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16.

Related Keywords

Dan Arias , Kayla Hostetler , Carrie Mckim , Stefan Lutz , John Maraganore , Kevin Norrett , Masad Damha , Evan Stampler , Jim Lalonde , Brandon Couillard , Synthesis Innovation Lab , Codexis Inc , Exchange Commission , Nestle Health Science , Nestle , Nasdaq , Alnylam Pharmaceuticals , Innovation Lab , Pfizer , Call Transcript February , Codexis Fourth Quarter , Full Year , Stephen Dilly , Codexi President , Chief Executive Officer , Chief Operating Officer , Sri Ryali , Chief Financial Officer , Private Securities Litigation Reform Act , Codex Hicap , Innovatus Capital , Strategic Advisory Board , Senior Vice President , Professor Masad Damha , Strategic Advisory , Pharmaceutical Manufacturing , Investor Relations , Bill Gate , Stocks To Buy , Most Freshwater , Nestle Health ,